Discover 928 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 928
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
for
Hepatocellular Carcinoma (HCC)
Location: Portland OR, Duarte CA, Nashville TN, Hackensack NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07291076
Phase 1, Phase 2, Recruiting
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Location: Portland OR, Los Angeles CA, Aurora CO, Minneapolis MN,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07024784
Phase 2, Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Portland OR, Clackamas OR, Vancouver WA, Oregon City OR,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase 3, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Portland OR, Clackamas OR, Oregon City OR, Newberg OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase 2, Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
for
Malignant Solid Neoplasm
Location: Portland OR, Clackamas OR, Vancouver WA, Oregon City OR,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 0+
Code: NCT06295367
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
for
Advanced Hepatocellular Carcinoma,
Location: Portland OR, Clackamas OR, Oregon City OR, Newberg OR,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07166406
Phase 3, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Portland OR, Salem OR, Redmond OR, Tacoma WA, Bend OR,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase 3, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: Portland OR, Clackamas OR, San Francisco CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase 2, Phase 3, Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Portland OR, Oregon City OR, Newberg OR, Post Falls ID,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06769126
Phase 2, Recruiting
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
for
Prostate Cancer
Location: Portland OR, Atlanta GA, Hackensack NJ
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07543055
Phase 1, Recruiting
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
for
Breast Neoplasms
Location: Portland OR, Los Angeles CA, Loveland CO, Greeley CO,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07287098
Phase 2, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Portland OR, Oregon City OR, Newberg OR, Hood River OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase 2, Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Portland OR, Dallas TX, Skokie IL, Ann Arbor MI,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06731478
Phase 3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Portland OR, Vancouver WA, Post Falls ID,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
for
Lung Neoplasm Malignant
Location: Portland OR, Chicago IL, Clermont FL
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07286149
Phase 1, Phase 2, Recruiting
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
for
NSCLC
Location: Portland OR, Seattle WA, Stanford CA, Orange CA,
Sponsor: Lung Cancer Mutation Consortium
Sex: All
Age: 0+
Code: NCT04712877
Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Location: Portland OR, Los Angeles CA, Duarte CA, San Diego CA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT06293898
Phase 1, Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)